Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to ...
当你接种疫苗或被病毒感染后,身体里会发生一场精密且高效的“武器升级”战。这场战斗的核心阵地就是淋巴结和扁桃体中的“生发中心”(Germinal Center)。在这里,B细胞(B cells)会经历快速增殖与基因突变,最终进化出能精准识别病原体的抗体 ...
Opportunities include automated closed systems, AI-enabled quality control, single-cell and cell therapy workflows, precision medicine, advanced diagnostics and emerging-market expansion.Dublin, Sept.
1don MSN
How does a bird virus infect a person? Surprising findings from B.C.’s human case of H5N1 avian flu
How do we know when an animal virus might pose a risk to humans? Canada confirmed a human case of H5N1 avian influenza (often ...
Natural killer cells have long been viewed as the immune system’s blunt but dependable first responders, capable of destroying tumor cells without the elaborate priming that T cells require. In r ...
When melanoma spreads to the brain, the outlook for patients has historically been grim, and one of the reasons lies in how ...
Data among 15 novel abstracts on IMAAVY to be presented at the MGFA Scientific Session during AANEM 2026 SPRING HOUSE, Pa., Sept. 29, 2026 // -- Johnson & Johnson (NYSE: JNJ) today announced new ...
Sustained clinical benefit and reversal of disability through one year support the potential to be the first approved therapy in SPS and first approved CAR T-cell therapy for autoimmune disease; ...
After hearing about antibiotic resistance and the existence of “superbugs,” I became the type of person who tried to avoid taking medication whenever I was sick. I worried that if I took medication ...
Gene-editing techniques could soon allow researchers to replace entire genes and engineer complex cellular circuits — if the ...
Morning Overview on MSN
Scientists find hidden immune hubs in the skull that fight brain cancer
Researchers at Washington University School of Medicine in St. Louis have identified immune structures inside skull bone ...
Roche has reported a phase 3 win for sefaxersen in kidney disease, teeing up talks with regulators about the path to approval for the Ionis Pharmaceuticals-partnered, would-be blockbuster drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results